市場調查報告書
商品編碼
1283945
鼠標模型市場規模、市場份額、應用分析、區域展望、增長趨勢、主要參與者、競爭戰略、預測,2023-2031 年Mice Model Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031 |
由於對個性化醫療的需求不斷增加、基因研究的進步以及慢性病患病率上升等多種因素,預計未來幾年全球小鼠模型市場將出現顯著增長。預計。 在 2023-2031 年的預測期內,全球小鼠模型市場規模預計將以 14% 的複合年增長率增長。 小鼠模型廣泛用於醫學研究,以研究各種疾病和病症,包括癌症、糖尿病和心血管疾病。 這些疾病在全球範圍內日益流行,預計將在未來幾年推動對小鼠模型的需求。 此外,對個性化醫療的需求不斷增加以及對新藥和治療的臨床前試驗的需求預計將進一步推動市場增長。 此外,新的轉基因小鼠模型的開發和基因研究的進步預計將對市場的增長做出重大貢獻。 使用小鼠模型研究特定基因的影響及其與環境的相互作用,提高了我們對各種疾病的理解,並促進了新療法的開發。 總體而言,對個性化醫療的需求不斷增長、基因研究的進步以及慢性病患病率的上升預計將在未來幾年推動小鼠模型市場的增長。
基因工程小鼠技術的出現是小鼠模型市場的一個裡程碑。 這項技術使科學家能夠改變小鼠的基因組成,以創建模仿人類遺傳疾病的模型。 該技術的進步使小鼠模型成為開發針對多種疾病的新療法和藥物的臨床前研究的重要組成部分,對它們的需求猛增。 此外,這項技術還減少了對非人類靈長類動物的研究使用,這具有倫理和財務影響。
癌症、糖尿病和自身免疫性疾病等慢性病患病率的增加是小鼠模型市場的另一個重要驅動力。 小鼠模型被廣泛用於研究這些疾病的機制並測試新的治療方法和藥物。 根據美國癌症協會的數據,2020 年美國將有大約 180 萬新發癌症病例和大約 60 萬癌症死亡病例。 這凸顯了對支持癌症研究和藥物開發的小鼠模型的高需求。
旨在根據患者的遺傳易感性提供適合個體患者的醫療服務的個性化醫療正在蓬勃發展。 小鼠模型在這一領域發揮著重要作用,因為它們使我們能夠在臨床前研究中檢驗個性化藥物的有效性和安全性。 此外,我們可以通過支持生物標誌物和藥物靶點的識別來加速精準醫療的發展。 隨著對個性化醫療的需求不斷增長,對小鼠模型的需求也有望增加。
在研究中使用動物的限制是小鼠模型市場的主要限制因素。 動物福利問題已經制定了必須遵守的嚴格規定,以確保符合道德規範的治療並最大程度地減少痛苦。 這些規定導致成本更高、監管批准時間更長,以及用於研究目的的動物可用性有限。 在某些情況下,完全禁止在研究中使用動物,並且需要替代研究方法,例如計算機建模或細胞培養。 例如,歐盟 (EU) 出台了關於保護用於科學目的的動物的指令 2010/63/EU,強制要求盡可能用非動物替代品代替動物試驗。 同樣,在美國,《動物福利法》(AWA) 和關於人道關懷和使用實驗室動物的公共衛生服務政策規範了動物在研究中的使用。 這些法規增加了替代方法和技術的使用,例如計算機建模、器官芯片和體外分析,這可能會阻礙小鼠模型市場的增長。 然而,儘管存在這些挑戰,小鼠模型仍然是研究中有價值的工具,動物福利實踐和替代方案的持續創新將有助於克服其中的一些障礙。
小鼠模型市場可按技術細分為 CRISPR/CAS9、顯微注射、胚胎幹細胞注射、核移植和其他技術。 在這些細分市場中,CRISPR/CAS9 技術細分市場預計將在 2023 年至 2031 年的預測期內以最高的複合年增長率增長。 這得益於CRISPR/CAS9技術在生成基因工程小鼠模型方面的準確性高、效率高等優勢。 此外,這項技術使研究人員能夠高精度地瞄準和修改特定基因,這對於闡明疾病的遺傳基礎和開發新療法至關重要。 按收入計算,顯微注射業務將在 2022 年佔據最大份額。 這是因為該技術已被廣泛應用於生成轉基因小鼠模型,用於研究各種人類疾病,如癌症、糖尿病和心血管疾病。 顯微注射允許研究人員將外來 DNA 引入小鼠基因組,從而開發出模擬人類疾病的基因工程小鼠模型。
全球小鼠模型市場可以根據藥物發現和開發、基礎研究和患者來源的異種移植 (PDX) 模型/異種移植等應用進行細分。 其中,藥物發現和開發板塊將在 2022 年佔據最大的市場份額,預計在 2023 年至 2031 年的預測期內將以較大的複合年增長率增長。 對個性化醫療的需求不斷增長以及製藥公司研發活動的增加是推動這一領域增長的主要因素。 此外,小鼠模型也廣泛用於臨床前研究,以評估新藥的安全性和有效性。 由於政府和私營公司增加對生物醫學研究的投資,預計基礎研究領域將以顯著的複合年增長率增長。 此外,對研究人類疾病及其遺傳基礎的基因工程小鼠模型的需求不斷增加,也促進了這一領域的增長。 預計 PDX 模型/異種移植物在預測期內將適度增長。 這些模型廣泛用於癌症研究和藥物開發,因為它們模仿了人類腫瘤的生物學行為。
北美在 2022 年佔據市場主導地位,佔銷售額的比例最高。 這是由於先進的醫療保健基礎設施的存在、研發投資的增加以及有利的政府舉措。 由於多家製藥和生物技術公司的存在以及學術實驗室對小鼠模型的廣泛研究,美國是該地區的一個重要市場。 歐洲的收入僅次於北美,預計在預測期內將出現顯著增長,這是由於對個性化醫療的日益關注以及對人性化小鼠模型的需求不斷增加。 亞太地區在 2023-2031 年的預測期內增長最快,原因是研發活動投資增加、對藥物發現和開發的關注度增加以及研究活動外包給中國和印度等國家的增加。預計創下高複合年增長率。 此外,由於慢性病患病率增加以及政府加大支持研發活動的力度,預計拉丁美洲和中東及非洲地區在預測期內將出現顯著增長。
全球鼠標模型市場競爭激烈,參與者眾多。 市場上的主要參與者包括 Envigo、Charles River Laboratories International, Inc.、The Jackson Laboratory、Laboratory Corporation of America Holdings (Envigo)、Janvier Labs、Taconic Biosciences, Inc. 和 genOway S.A.,這些公司投資於研發活動和新產品開發,以保持其市場地位。 此外,參與者還注重戰略聯盟和聯合研究以增加市場份額。 例如,2020 年,Charles River Laboratories International, Inc. 與美國國家過敏和傳染病研究所 (NIAID) 合作開展了 COVID-19 的臨床前研究。 總體而言,市場參與者正專注於各種策略,以保持其市場地位並擴大其在全球鼠標模型市場的影響力。 各種應用對小鼠模型的需求不斷增加以及對個性化醫療的需求預計將推動未來幾年的市場增長。
The global mice model market is expected to experience significant growth in the coming years, driven by several factors such as increasing demand for personalized medicine, advancements in genetic research, and rising prevalence of chronic diseases. The global mice model market size is expected to grow at a CAGR of 14% during the forecast period of 2023 to 2031. Mice models are widely used in medical research to study various diseases and disorders such as cancer, diabetes, and cardiovascular diseases. The increasing prevalence of these diseases worldwide is expected to drive the demand for mice models in the coming years. Additionally, the growing demand for personalized medicine and the need for preclinical testing of new drugs and therapies are expected to further drive market growth.Furthermore, the development of new genetically modified mice models and the advancements in genetic research are expected to significantly contribute to market growth. The use of mice models in studying the effects of specific genes and their interaction with the environment has provided a better understanding of various diseases and has facilitated the development of new treatments.Overall, the increasing demand for personalized medicine, advancements in genetic research, and rising prevalence of chronic diseases are expected to drive the growth of the mice model market in the coming years.
The advent of genetically modified mice technology has been a game-changer for the Mice Model Market. The technology enables scientists to alter the genetic makeup of mice and create models that mimic human genetic disorders. This advancement has led to a surge in the demand for mice models, as they play a critical role in preclinical research for developing new therapies and drugs for various diseases. Moreover, this technology has also reduced the use of non-human primates in research, which has ethical and financial implications.
The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune diseases is another significant driver of the Mice Model Market. Mice models are extensively used to conduct research on the mechanisms of these diseases and test new therapies and drugs. According to the American Cancer Society, there were approximately 1.8 million new cancer cases and 0.6 million cancer deaths in the US in 2020. This highlights the significant demand for mice models to support cancer research and drug development.
There has been a growing trend in personalized medicine, which aims to tailor medical treatment to individual patients based on their genetic makeup. Mice models play a critical role in this field as they enable researchers to study the efficacy and safety of personalized drugs in preclinical trials. Moreover, mice models also facilitate the development of precision medicine by helping researchers to identify biomarkers and potential drug targets. As the demand for personalized medicine continues to increase, the demand for mice models is also expected to rise.
Restrictions on the use of animals in research are a significant restraint in the mice model market. Animal welfare concerns have led to strict regulations that must be followed to ensure ethical treatment and minimize suffering. These regulations have resulted in higher costs, increased time for regulatory approval, and limited availability of animals for research purposes. In some cases, the use of animals in research is completely prohibited, resulting in the need for alternative research methods, such as computer modeling or cell cultures. For instance, the European Union (EU) introduced Directive 2010/63/EU on the protection of animals used for scientific purposes, which mandates that animal experiments must be replaced with non-animal alternatives whenever possible. Similarly, in the United States, the Animal Welfare Act (AWA) and the Public Health Service Policy on Humane Care and Use of Laboratory Animals regulate the use of animals in research. These regulations have led to an increase in the use of alternative methods and technologies, such as in silico modeling, organ-on-a-chip, and in vitro assays, which may hinder the growth of the mice model market. However, despite these challenges, mice models remain a valuable tool in research, and continued innovation in animal welfare practices and alternative methods may help overcome some of these restraints.
The Mice Model Market can be segmented based on technology into CRISPR/CAS9, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Among these segments, the CRISPR/CAS9 technology segment is expected to grow at the highest CAGR during the forecast period of 2023 to 2031. This is due to the advantages of the CRISPR/CAS9 technology, such as high precision and efficiency in generating genetically modified mice models. Additionally, this technology enables researchers to target specific genes and modify them with high accuracy, which is crucial for understanding the genetic basis of diseases and developing new treatments.In terms of revenue, the microinjection segment held the largest share in 2022. This is due to the wide application of this technology in generating transgenic mice models for studying a range of human diseases, including cancer, diabetes, and cardiovascular diseases. Microinjection enables researchers to introduce foreign DNA into the mouse genome, resulting in the development of genetically modified mice models that mimic human diseases.
The global mice model market can be segmented based on its applications, which include drug discovery and development, basic research, and patient-derived xenograft (PDX) models/xenografts. Among these, the drug discovery and development segment held the largest market share in terms of revenue in 2022 and is expected to grow at a significant CAGR during the forecast period of 2023 to 2031. The growing demand for personalized medicine and increasing R&D activities by pharmaceutical companies are some of the key factors driving the growth of this segment. Moreover, mice models are widely used for preclinical studies to evaluate the safety and efficacy of new drugs. The basic research segment is also expected to grow at a substantial CAGR owing to the increasing investments by governments and private organizations in biomedical research. Additionally, the rising demand for genetically modified mice models for studying human diseases and their genetic basis is further contributing to the growth of this segment. The PDX models/xenografts segment is expected to witness moderate growth during the forecast period. These models are widely used for cancer research and drug development, as they mimic the biological behavior of human tumors.
North America dominated the market, accounting for the highest revenue percentage in 2022. This is due to the presence of advanced healthcare infrastructure, increased investment in research and development, and favourable government initiatives. The US is the leading market in the region, owing to the presence of several pharmaceutical and biotech companies, along with academic research institutes conducting extensive research on mice models. Europe follows North America in terms of revenue share, and the region is projected to witness significant growth during the forecast period due to increasing focus on personalized medicine and rising demand for humanized mice models. The Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2023 to 2031, due to increasing investment in research and development activities, growing focus on drug discovery and development, and increasing outsourcing of research activities to countries like China and India. Latin America and the Middle East and Africa regions are also projected to witness significant growth during the forecast period due to the growing prevalence of chronic diseases and increasing government initiatives to support research and development activities.
The global mice model market is highly competitive with the presence of various players. Some of the key players operating in the market include Envigo, Charles River Laboratories International, Inc., The Jackson Laboratory, Laboratory Corporation of America Holdings (Envigo), Janvier Labs, Taconic Biosciences, Inc., and genOway S.A. These companies are investing in R&D activities and new product development to maintain their position in the market.In addition, players are also focusing on strategic partnerships and collaborations to expand their market share. For instance, in 2020, Charles River Laboratories International, Inc. partnered with The National Institute of Allergy and Infectious Diseases (NIAID) to conduct preclinical research on COVID-19.Overall, the market players are focusing on various strategies to maintain their market position and expand their presence in the global mice model market. The increasing demand for mice models in various applications and the need for personalized medicine are expected to drive the growth of the market in the coming years.
This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Mice Model market are as follows:
Micro and macro environment factors that are currently influencing the Mice Model market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.